Gregor B. E. Jemec

41.0k citations
645 papers · 25.4k · 11 hit papers · h-index 82

Impact in

  • Dermatology top 0.01%
    • Hidradenitis Suppurativa and Treatments
    • Dermatology and Skin Diseases
    • Chemotherapy-related skin toxicity
  • Surgery top 0.1%
    • Colorectal and Anal Carcinomas
    • Anorectal Disease Treatments and Outcomes

Papers in

    • Hidradenitis Suppurativa and Treatments 258
    • Dermatology and Skin Diseases 50
    • Chemotherapy-related skin toxicity 47
    • Nail Diseases and Treatments 42
    • Nonmelanoma Skin Cancer Studies 39

Gregor B. E. Jemec

601 papers receiving 24.5k citations

Gregor B. E. Jemec's Hit Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials 2024 · 87 citations
870+10+20Years since publication250500750

Peers

Gregor B. E. Jemec
Comparison fields: 5 of 189
  • Dermatology 17.3k
  • Surgery 7.5k
  • Immunology and Allergy 899
  • Epidemiology 4.8k
  • Biophysics 554
Replace Peter Altmeyer with:
Peter Altmeyer Germany
Thomas Ruzicka Germany
Wolfram Sterry Germany
Peter Elsner Germany
Uwe Wollina Germany
Brigitte Dréno France
Torello Lotti Italy
Gérald Pierard Belgium
Alain Taı̈eb France
Otto Braun‐Falco Germany
Gregor B. E. Jemec relative to Peter Altmeyer Germany Peter Altmeyer's profile →
Citations per field
00.5×9.1×
Peter Altmeyer · 1×
Citations per year

Countries citing papers authored by Gregor B. E. Jemec

Since Specialization
Citations

This map shows the geographic impact of Gregor B. E. Jemec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor B. E. Jemec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor B. E. Jemec more than expected).

Fields of papers citing papers by Gregor B. E. Jemec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregor B. E. Jemec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor B. E. Jemec. The network helps show where Gregor B. E. Jemec may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregor B. E. Jemec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregor B. E. Jemec Line = papers co-authored together Gregor B. E. Jemec links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 645 papers — load more, or switch the sort, to bring in the rest.

#Work
1
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Hit paper breakdown →
2015762
2
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
Hit paper breakdown →
2014657
3
Hidradenitis Suppurativa
Hit paper breakdown →
2012608
4
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
Hit paper breakdown →
2009419
5
The prevalence of hidradenitis suppurativa and its potential precursor lesions
Hit paper breakdown →
1996392
6
Hidradenitis suppurativa
Hit paper breakdown →
2020390
7
Hidradenitis Suppurativa
Hit paper breakdown →
2017323
8
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Hit paper breakdown →
2012312
9 2010285
10 2006278
11
Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation
Hit paper breakdown →
2015275
12 2001273
13 2008267
14 1998263
15 2013252
16
Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life
Hit paper breakdown →
2020240
17 2008231
18 2017222
19 2006204
20 2012203

About Gregor B. E. Jemec

Gregor B. E. Jemec is a scholar working on Dermatology, Epidemiology, Surgery, Oncology and Biomedical Engineering, having authored 645 papers that have together received 25.4k indexed citations. Recurring topics across this work include Hidradenitis Suppurativa and Treatments (258 papers), Colorectal and Anal Carcinomas (86 papers), Dermatology and Skin Diseases (50 papers), Chemotherapy-related skin toxicity (47 papers), Cutaneous Melanoma Detection and Management (45 papers), Optical Coherence Tomography Applications (44 papers), Nail Diseases and Treatments (42 papers) and Nonmelanoma Skin Cancer Studies (39 papers). The work is most often cited by research in Dermatology (17.3k citations), Surgery (7.5k citations), Immunology and Allergy (899 citations), Epidemiology (4.8k citations) and Biophysics (554 citations). Gregor B. E. Jemec has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Errol P. Prens, Ditte Marie Lindhardt Saunte, Mette Mogensen, Christos C. Zouboulis, I.M. Miller, Ximena Wortsman, Lennart Emtestam, Alexa B. Kimball, Hessel H. van der Zee and Kristina Sophie Ibler. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, Dermatology, Acta Dermato Venereologica and Archives of Dermatological Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact